规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50μL*10mM(DMSO) | ¥99随货¥69 | 咨询 | |
10mM*1mL(DMSO) | ¥501 | 咨询 | |
1mg | ¥186 | 咨询 | |
5mg | ¥409 | 咨询 | |
10mg | ¥693 | 咨询 | |
50mg | ¥3024 | 咨询 | |
100mg | ¥4969 | 咨询 | |
1g | ¥12745 | 咨询 |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | GSK-3 ↓ ↑ | GSK-3α ↓ ↑ | GSK-3β ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZD2858 |
+
GSK-3, IC50: 68 nM | 99% | |||||||||||||||||
Bikinin | ✔ | 99%+ | |||||||||||||||||
GSK 3 Inhibitor IX |
++++
GSK-3, IC50: 5 nM | 99%+ | |||||||||||||||||
AZD1080 |
+++
GSK-3α, IC50: 6.9 nM |
++
GSK-3β, IC50: 31 nM | 99%+ | ||||||||||||||||
BIO-acetoxime |
+++
GSK-3α, IC50: 10 nM |
+++
GSK-3β, IC50: 10 nM | 95% | ||||||||||||||||
SB-216763 |
++
GSK-3α, IC50: 34.3 nM |
++
GSK-3β, IC50: ~34.3 nM | 98% | ||||||||||||||||
SB 415286 |
+
GSK-3α, IC50: 78 nM |
+
GSK-3β, IC50: ~78 nM | 99%+ | ||||||||||||||||
CHIR-98014 |
++++
GSK-3α, IC50: 0.65 nM |
++++
GSK-3β, IC50: 0.58 nM | 98% | ||||||||||||||||
LY2090314 |
++++
GSK-3α, IC50: 1.5 nM |
++++
GSK-3β, IC50: 0.9 nM | 99%+ | ||||||||||||||||
CHIR 99021 |
+++
GSK-3α, IC50: 10 nM |
++++
GSK-3β, IC50: 6.7 nM | 99%+ | ||||||||||||||||
TDZD-8 |
+
GSK-3β, IC50: 2 μM | 99%+ | |||||||||||||||||
Indirubin |
+
GSK-3β, IC50: 0.6 μM | 98% | |||||||||||||||||
IM-12 |
++
GSK-3β, IC50: 53 nM | 98% | |||||||||||||||||
TWS119 |
++
GSK-3β, IC50: 30 nM | 99% | |||||||||||||||||
1-Azakenpaullone |
+++
GSK-3β, IC50: 18 nM | 99%+ | |||||||||||||||||
AR-A014418 |
++
GSK-3β, Ki: 38 nM | 99%+ | |||||||||||||||||
Tideglusib |
+
GSK-3β, IC50: 60 nM | 98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | GSK-3 (Glycogen synthase kinase 3) is a serine/threonine protein kinase, consisting of GSK-3 and subunit, which plays a key role in many different biological processes including tumorigenesis, cell survival, and developmental patterning. GSK-3 is constitutively active in non-stimulated cells and can negatively regulate canonical Wnt/-catenin signaling[2][3]. SB-216763 is a maleimide-derived GSK-3 inhibitor with IC50 value of 34nM for GSK-3K (measured by recombinant human GSK-3K). SB-216763 is equally effective at inhibiting GSK-3 and SB-216763<6uM can induce transcription of a-catenin-LEF/TCF regulated reporter gene dose-dependently in serum starved HEK293 for 16h [1]. Treatment with 5uM SB-216763 for 4h can increase levels of cytoplasmic-catenin, which is a target negatively regulated by GSK-3, in both serum-starved cerebellar granule neurons and HEK293 cells. SB-216763 (3-5uM) can confer a marked reduction in GSK-3-dependent tau phosphorylation at Ser202-phosphoepitopes in transfected HEK293 cells and endogenous tau protein in cerebellar granule neurons[4]. SB-216763 can cross the blood–brain barrier and enter the CNS in both rodents and nonhuman primates[5]. Co-infusion of SB-216763 corrected all responses to Aβ infusion except the induction of gliosis and behavioral deficits in the Morris water maze of rats [6]. |
作用机制 | Mechanism: SB-216763 can inhibit GSK-3 in an ATP competitive manner. [1] |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
HEK293 cells | Function assay | Glycogen synthase activity of HEK293 cells, inhibition of GSK3-beta, EC50=0.2 μM | 12941331 | ||
human 5637 cell | Growth inhibition assay | Inhibition of human 5637 cell growth in a cell viability assay, IC50=25.8111 μM | SANGER | ||
human A101D cell | Growth inhibition assay | Inhibition of human A101D cell growth in a cell viability assay, IC50=30.9784 μM | SANGER | ||
human A2058 cell | Growth inhibition assay | Inhibition of human A2058 cell growth in a cell viability assay, IC50=13.469 μM | SANGER | ||
计算器 | ||||
存储液制备 | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 2.69mL 0.54mL 0.27mL | 13.47mL 2.69mL 1.35mL | 26.94mL 5.39mL 2.69mL |
CAS号 | 280744-09-4 |
分子式 | C19H12Cl2N2O2 |
分子量 | 371.217 |
别名 | |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,Store in freezer, under -20°C |
溶解方案 | DMSO: 105 mg/mL(282.85 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 | IP 2% DMSO+2% Tween80+30% PEG300+water 1 mg/mL clear PO 0.5% CMC-Na 39 mg/mL suspension |